AbD-Serotec/Tocilizumab抗体| AbD 22155_hIgG1/0.1 mg/HCA257P

价格
面议
货号:HCA257P
浏览量:127
品牌:AbD Serotec
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Human anti tocilizumab, clone AbD22155_hIgG1 is a non-paratope specific, anti-idiotypic antibody that binds to free tocilizumab and also to tocilizumab in bound to its target, human interleukin-6 receptor (IL-6R). The antibody can be used to measure total levels of tocilizumab and biosimilar products in bioanalytical assays.Clone AbD22155_hIgG1 can be used to develop a pharmacokinetic (PK) bridging assay to measure total drug levels (free drug, partially bound and fully bound). The antibody, HRP-conjugated and in full immunoglobulin (Ig) format, is recommended as the detection antibody, paired with capture antibody clone AbD21362 (HCA252) in monovalent Fab format. The antibody in Ig format can also be used to develop and calibrate immune response assays to measure the anti-drug antibody (ADA) response in patient sera.Tocilizumab, marketed under the brand name RoActemra® in Europe and Actemra® in North America, is a humanized IgG1/kappa monoclonal antibody approved for the treatment of moderate to severe rheumatoid arthritis and for the treatment of systemic juvenile idiopathic arthritis. The therapeutic antibody, directed against IL-6R, acts by blocking the binding of IL-6R (both the soluble form, sIL-6R, and the membrane bound form, mIL-6R) to IL-6, thus impeding the pro-inflammatory properties of this cytokine.View a summary of all anti-tocilizumab antibodies

Product Details

Product Form
Human IgG1 antibody (lambda light chain) selected from the HuCAL® phage display library and expressed in a human cell line. Conjugated to horseradish peroxidase (HRP) - liquid.
Product Form
Human IgG1 antibody (lambda light chain) selected from the HuCAL® phage display library and expressed in a human cell line. This antibody is supplied as a liquid.
Preparation
Purified IgG prepared by affinity chromatography on Protein A
Preparation
Purified IgG prepared by affinity chromatography on Protein A
Buffer Solution
Phosphate buffered saline
Buffer Solution
Phosphate buffered saline
Preservative Stabilisers
0.01% Thiomersal
Preservative Stabilisers
0.01% Thiomersal
Immunogen
Tocilizumab and tocilizumab-sIL-6R complex
Affinity
The monovalent intrinsic affinity of this antibody was measured as KD = 31 nM by real time, label free molecular interaction analysis on immobilized tocilizumab.
Approx. Protein Concentrations
IgG concentration 0.1 mg/ml
Approx. Protein Concentrations
IgG concentration 0.5 mg/ml

Storage Information

Storage
Store at -70oC.Storage in frost-free freezers is not recommended.This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody.
Storage
Store at +4oC or at -20oC if preferred.Storage in frost-free freezers is not recommended.This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use
Guarantee
12 months from date of despatch
Guarantee
12 months from date of despatch

More Information

Acknowledgements
Sold under license of U.S. Patents 6753136, 7785859 and 8273688 and corresponding patents. This antibody was developed by Bio-Rad, Zeppelinstr. 4, 82178 Puchheim, Germany.Actemra® and RoActemra® are registered trademarks of Hoffman-La Roche and Chugai Pharmaceuticals co., Ltd.
Acknowledgements
Sold under license of U.S. Patents 6753136, 7785859 and 8273688 and corresponding patents. This antibody was developed by Bio-Rad, Zeppelinstr. 4, 82178 Puchheim, Germany.Actemra® and RoActemra® are registered trademarks of Hoffman-La Roche and Chugai Pharmaceuticals co., Ltd.
Licensed Use
For in vitro research purposes and for commercial applications for the provision of in vitro testing services to support preclinical and clinical drug development. Any re-sale in any form or any other commercial application needs a written agreement with Bio-Rad.
Regulatory
For research purposes only

Applications of Tocilizumab antibody

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application NameVerifiedMin DilutionMax Dilution
ELISA
ELISA
      Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
      Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
      Technical Advice
      Recommended protocols and further information about HuCAL recombinant antibody technology can be found in theHuCAL Antibodies Technical Manual
      Technical Advice
      Recommended protocols and further information about HuCAL recombinant antibody technology can be found in theHuCAL Antibodies Technical Manual
      ELISA
      This product may be used in a direct ELISA or as a detection reagent in a bridging ELISA together with HCA252 as the capture reagent.Protocol: PK bridging ELISA to measure total drug
      ELISA
      This product may be used in a direct ELISA or as a detection reagent in a bridging ELISA together with HCA252 as the capture reagent.Protocol: PK bridging ELISA to measure total drug

      Useful Reagents Available

      DescriptionProduct CodeApplicationsPack SizeList PriceQuantity
      Hispec Assay DiluentBUF049AE IY 50 ml
      Human anti Tocilizumab HCA252E* 0.1 mgloader
      Human anti TocilizumabHCA253E 0.1 mgloader
      Human anti TocilizumabHCA254E 0.1 mgloader
      Human anti TocilizumabHCA255E 0.1 mgloader
      Human anti TocilizumabHCA256E 0.1 mgloader
      Hispec Assay DiluentBUF049AE IY 50 ml
      Human anti TocilizumabHCA252E* 0.1 mgloader
      Human anti TocilizumabHCA253E 0.1 mgloader
      Human anti TocilizumabHCA254E 0.1 mgloader
      Human anti TocilizumabHCA255E 0.1 mgloader
      Human anti TocilizumabHCA256E 0.1 mgloader
      LYNX Rapid HRP Antibody Conjugation KitLNK001PCJ 1 Conjugation For 400µg Antibody
      LYNX Rapid HRP Antibody Conjugation KitLNK002PCJ 3 Conjugations For 400µg Antibody
      LYNX Rapid HRP Antibody Conjugation KitLNK003PCJ 1 Conjugation For 4mg Antibody
      LYNX Rapid HRP Antibody Conjugation KitLNK004PCJ 5 Conjugations For 4mg Antibody
      LYNX Rapid HRP Antibody Conjugation KitLNK005PCJ1 Conjugation For 20mg Antibody
      LYNX Rapid HRP Antibody Conjugation KitLNK006PCJ 3 Conjugations For 40µg Antibody

      Product Specific References

      References for Tocilizumab antibody

      1. Kashiwagi, N. et al. (2017) Method for measuring anti-drug antibodyUS Patent Application US20170315118A1
      View more products with Tocilizumab specificity
      AbD Serotec用于研究和诊断分析开发的抗体和抗原Bio-Rad提供超过10,000种抗体,以及适合进行研究和体外诊断测定的抗原,缓冲液和试剂。特异性和性能在我们的抗体生产中同等重要。对于所述应用,性能得到保证。无论您需要测试一系列现成的抗体以进行分析开发,还是需要大量抗体来进行分析制造,请咨询我们的专家以找到满足您需求的解决方案。查找有关针对化验制造商量身定制的产品和服务的更多信息仅8周即可产生重组单克隆抗体完整的人类抗体对照和校准品,可替代采购阳性对照血清客户提供的杂交瘤的抗体生产大量生产目录抗体(批量)专门的ELISA缓冲液和底物